Triple drug combinations effective against drug-resistant malaria

12 March 2020, Bangkok (Thailand) – Adding a third antimalarial drug to current artemisinin-combination therapies (ACTs) provides effective treatment against multidrug-resistant falciparum malaria in Southeast Asia, say Mahidol and Oxford University researchers in a study published today in The Lancet

tracii_drc_mehul_dhorda_dsc04237.jpg